Mursla to present at Bio-Europe Spring 2023
Mursla was selected to present at the largest pharmaceutical and biotech partnering event in Europe this Spring
top of page
Nextgen multi-omics liquid biopsy tests
Real time analysis of tissue-specific bioactivity in blood via Extracellular Vesicles (EVs)
WHAT WE ANALYSE
Tissue-specific EVs in blood
Extracellular Vesicles have been shown to reflect the state of their cellular sources, transporting specific ‘-omics’ information (DNA, RNA, proteins, lipids and metabolites) either locally or to distant sites via the circulatory system, including blood.
Extracellular Vesicles from specific tissue are dynamic circulating snapshots of tissue activity and can be analysed non-invasively with a blood draw.
HOW WE ANALYSE
Novel EV characterisation platform ExoPheno
TM
ExoPheno™ analyses the multi-omics cargo of EVs in blood from a selected tissue of origin. It enables the creation of next generation liquid biopsy blood tests.
It consists of proprietary and patented technologies, which integrate wet lab (validated EV tissue-of-origin markers, adaptative linker cleavage, pre-analytical multi-omics sequencing workflow and ultrasensitive EV marker detection systems) and dry lab analysis via machine learning.
OUR PARTNERS
Supporting world-class research
.png)
.jpg)
bottom of page